Reproducibilty of Magnetization Transfer Ratio Histogram–Derived Measures of the Brainin Healthy Volunteers

References

1. ↵
   Filippi M. The role of non-conventional magnetic resonance techniques in monitoring evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64[suppl]:S52-S58
2. ↵
   van Buchem MA, McGowan JC, Kolson DL, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636

   PubMedWeb of Science
3. ↵
   van Waesberghe JHTM, van Walderveen MAA, de Groot C, et al. Postmortem correlation between axonal loss, MTR, and hypointensity on T1 SE in MS. Proc Int Soc Magn Reson Med 1998;2:1334
4. ↵
   Lexa FJ, Grossman RI, Rosenquist AC. MR of Wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. AJNR Am J Neuroradiol 1994;15:201-212

   Abstract/FREE Full Text
5. Dousset V, Brochet B, Vital A, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 1995;16:225-231

   Abstract/FREE Full Text
6. Kimura H, Meaney DF, McGowan JC, et al. Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: characterization by magnetization transfer ratio with histopathologic correlation. J Comp Assist Tomogr 1996;20:540-546

   CrossRefPubMedWeb of Science
7. ↵
   Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999;52:588-594

   Abstract/FREE Full Text
8. ↵
   Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-1608

   Abstract/FREE Full Text
9. ↵
   Filippi M, vanWaesberghe JH, Horsfield MA, et al. Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials. Neurology 1997;49:371-377

   Abstract/FREE Full Text
10. ↵
    Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688

    Abstract/FREE Full Text
11. ↵
    Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1–100 MHz: dependence of tissue type: NMR frequency, temperature, species, excision, and age. Med Phys 1984;11:425-448

    CrossRefPubMedWeb of Science
12. ↵
    Rovaris M, Rocca MA, Sormani MP, Comi G, Filippi M. Reproducibility of brain MRI lesion volume measurements in multiple sclerosis using a local thresholding technique: the effects of formal operator training. Eur Neurol 1999;41:226-230

    CrossRefPubMedWeb of Science